News
Popular vitamins taken by one in four Americans and sold at major retailers like ALDI have been recalled due to ...
13h
Zacks Investment Research on MSNADMA Looks to Expand Asceniv's Label: Will This Boost Sales?ADMA Biologics ADMA markets plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain ...
FARMINGDALE, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (OTCQX: ENZB) ("Enzo” or the "Company”) today ...
Introduction The global bioconjugation market is witnessing robust growth, primarily driven by the expanding demand for targeted therapies and ...
Over the past 10 years, the market for monoclonal antibodies has grown exponentially. This focus issue brings together articles on the basic biology of antibodies and their therapeutic use ...
The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be around ~USD 150 billion. In 2021, five out of the top 10 selling drugs were ...
In the Phase IIIB APPULSE-PNH study, adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who switched to Fabhalta experienced clinically meaningful improvements in hemoglobin (Hb) levels of ...
Importantly, antibody alterations achieved by genetic means or active and passive immunization strategies in preclinical studies can improve or aggravate atherosclerosis. Additionally, a wide range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results